Tech & AI

Celltrion CT-P71 earns FDA Fast Track designation (April 9)

Nectin-4-targeted antibody-drug conjugate for advanced urothelial cancer. Korean biosimilar company's ADC challenge lands accelerated review.

Primary sources · 1
FDA Fast Track April
← View the full 2026-04-10 (Friday) issue
What you're reading now arrives in your inbox daily at 21:00 UTC.

Get today's brief every day at 21:00 UTC

7 must-reads · 17 fields · tracked storylines delivered to your inbox daily. Pick only the fields you want; unsubscribe anytime.

Past issues →